Bortezomib, rituximab, and risk of graft-versus-host disease (GVHD) after BEAM conditioning for allogeneic stem cell transplantation (alloSCT).

被引：0
|
作者：
Chamoun, Kamal
Gulbis, Alison M.
Milton, Denai
Jabbour, Elias
Turturro, Francesco
Khouri, Issa F.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18543
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Bortezomib for the prevention and treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Al-Homsi, Ahmad Samer
    Feng, Yuxin
    Duffner, Ulrich
    Al Malki, Monzr M.
    Goodyke, Austin
    Cole, Kelli
    Muilenburg, Marlee
    Abdel-Mageed, Aly
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : 771 - 777
  • [2] Graft-versus-host disease (GVHD) following allogeneic blood stem cell transplantation: Risk factor analysis
    Tarantolo, SR
    Bishop, MR
    Pavletic, ZS
    Kollath, J
    Lynch, J
    Reed, EC
    Bierman, PJ
    Vose, JM
    Gross, TG
    Armitage, JO
    Kessinger, A
    BLOOD, 1997, 90 (10) : 442 - 442
  • [3] Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL
    Nash, RA
    Storb, R
    CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) : 674 - 680
  • [4] Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
    Westeneng, Arnaud C.
    Hettinga, Ymkje
    Lokhorst, Henk
    Verdonck, Leo
    van Dorp, Suzanne
    Rothova, Aniki
    CORNEA, 2010, 29 (07) : 758 - 763
  • [5] INCIDENCE OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS WITH ALLOGENEIC PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NON-MYELOABLATIVE CONDITIONING
    Cantu, O. G.
    Gutierrez, H.
    Ruiz, G.
    Mancias, C.
    Martinez, S. A.
    Gonzalez, O.
    Jaime, J. C.
    Gomez, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S314 - S314
  • [6] INCIDENCE OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS WITH ALLOGENEIC PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER A NON-MYELOABLATIVE CONDITIONING
    Cantu, O.
    Gutierrez, H.
    Ruiz, G.
    Lopez, A.
    Mancias, C.
    Martinez, S.
    Gonzalez, O.
    Jaime, J.
    Gomez, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 653 - 653
  • [7] Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant
    Marini, Bernard L.
    Markstrom, Denise
    Frame, David
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (04) : 255 - 263
  • [8] Effect of intravenous busulfan versus total body irradiation on donor chimerism and acute graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (AlloSCT) in mice
    Wang, J
    Zhou, XT
    Symons, H
    Levy, MY
    Fuchs, EJ
    BLOOD, 2005, 106 (11) : 397B - 397B
  • [9] Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children
    Kondo, M
    Kojima, S
    Horibe, K
    Kato, K
    Matsuyama, T
    BONE MARROW TRANSPLANTATION, 2001, 27 (07) : 727 - 730
  • [10] Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Smith, TL
    Folloder, J
    Khouri, I
    Ueno, NT
    Mehra, R
    Körbling, M
    Huh, YO
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    van Besien, K
    Andersson, BS
    Anderlini, P
    Champlin, R
    BLOOD, 1999, 94 (04) : 1465 - 1470
12345